Lindsay Rosenwald

Lindsay Rosenwald

Verkställande Direktör på FORTRESS BIOTECH, INC.

Förmögenhet: 15 M $ per 2026-05-31

71 år
Health Technology
Finance
Consumer Services

Profil

Dr. Lindsay A. Rosenwald, MD, is an Executive Chairman at Cyprium Therapeutics, Inc., an Executive Chairman at Helocyte, Inc., an Executive Chairman at Journey Medical Corp., a Chairman, President & Chief Executive Officer at Fortress Biotech, Inc. and an Executive Chairman at Cellvation, Inc. He is on the Board of Directors at Mustang Bio, Inc., Avenue Therapeutics, Inc., Baergic Bio, Inc. and Caelum Biosciences, Inc. Dr. Rosenwald was previously employed as a Non-Executive Director by Checkpoint Therapeutics, Inc., a Co-Chairman & Chief Executive Officer by CB Pharma Acquisition Corp., a Co-Founder by TG Therapeutics, Inc., a Partner by Opus Point Partners Management LLC (Investment Management), a Chairman by Paramount Acquisition Corp., a Chairman & Chief Executive Officer by Paramount BioCapital, Inc., a Founder, Chairman & Chief Executive Officer by Paramount BioCapital Asset Management, Inc., a Founder, Chairman & Chief Executive Officer by Paramount BioSciences LLC, a Managing Director by Harris & Parks, Inc., and a Securities Analyst by Ladenburg Thalmann & Co., Inc. He also served on the board at Cougar Biotechnology, Inc. /Old/ and Keryx Biopharmaceuticals, Inc. He received his undergraduate degree from The Pennsylvania State University and a doctorate degree from Temple University School of Medicine.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-04-16 4 586 841 ( 13,81 % ) 13 M $ 2026-05-31
2025-08-05 387 616 ( 1,8 % ) 2 M $ 2026-05-31
2025-11-25 4 820 ( 0,15 % ) 1 446 $ 2026-05-31
2025-11-18 342 ( 0,01 % ) 229 $ 2026-05-31

Aktiva positioner av Lindsay Rosenwald

FöretagPositionStart
FORTRESS BIOTECH, INC. Verkställande Direktör 2013-12-20
AVENUE THERAPEUTICS, INC. Direktör/Styrelseledamot 2023-03-07
MUSTANG BIO, INC. Direktör/Styrelseledamot 2015-03-13
JOURNEY MEDICAL CORPORATION Ordförande 2014-10-01
Grundare 2017-01-01
Direktör/Styrelseledamot -
Grundare 2015-01-01
Ordförande -
Direktör/Styrelseledamot -

Tidigare kända positioner av Lindsay Rosenwald

FöretagPositionSlut
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Se detaljerna i Lindsay Rosenwalds erfarenhet

Lindsay Rosenwalds utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

41

Första gradens relationer

23

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag23

Finance

Health Technology

Health Technology

Finance

Finance

Health Technology

Health Technology

Consumer Services

Finance

Finance

Finance

D.H. Blair & Co., Inc.

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Lindsay Rosenwald
- 40% : De bästa verktygen för abonnenter som vill hitta morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU